Brendan Raizenne retweetledi

🚨 In our meta-analysis in @EUplatinum, longer RCT follow-up now provides HIGH certainty in a prostate cancer mortality benefit from screening
authors.elsevier.com/a/1n2mP_6tuO0T…
Earlier syntheses found uncertain evidence of little or no PCSM benefit
Some thoughts/highlights below 👇


English
























